Biotech veterans and critics found new company to undercut drug prices – CNBC
- Biotech veterans and critics found new company to undercut drug prices CNBC
- A Pharma Startup Launches With $200 Million In Funding And A Strategy To Make Drugs Faster, Cheaper Forbes
- Start-up proposes ‘third way’ to cut US drug prices Financial Times
- A health care veteran tries to upend the system and bring drug prices down STAT
- JetBlue, but for biopharma: Alexis Borisy’s EQRx nabs $200M, takes aim at drug prices FierceBiotech
- View full coverage on Google News
Source: Business News Feed